Glenmark Life Sciences inks CDMO supply deal with a Japanese pharma innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Subscribe To Our Newsletter & Stay Updated